Moving the HME Industry Forward

Respiratory/Sleep

Revenue Up at ResMed – Visit Them at Booth #2011

October 26, 2015

SAN DIEGO – Quarterly revenue for Medtrade exhibitor ResMed was $411.6 million, an 8% increase compared with the quarter ended Sept 30, 2014 (a 15% increase on a constant currency basis).

“Our global team was able to drive strong double-digit constant currency growth in the first quarter of fiscal year 2016.  This result was led by 39 percent flow generator and 9 percent mask growth in the Americas,” said Mick Farrell, ResMed’s CEO. “We are investing for ongoing expansion and leadership in our high-growth regions. In October, we completed the acquisition of Curative Medical, making our combined ResMed and Curative business the market leader in sleep-disordered breathing and respiratory care in China.”

Farrell continued: “It has been a year since we launched our Air Solutions Platform. We have made incredible progress, with over one million patients with cloud-connected devices on bedside tables, providing actionable data every day for patients, customers, providers and payors. Our leading informatics capabilities enable our global team to enhance and deliver the most innovative products and solutions that improve patient outcomes, create efficiencies for our customers, help providers better manage chronic disease and lower healthcare costs. We have established ourselves as leaders in the field of connected care and digital health.”